ABSTRACT
The Tip protein of Herpesvirus saimiri strain 484C binds to and activates the Lck tyrosine protein kinase. Two sequences in the Tip protein were previously shown to be involved in binding to Lck. A proline-rich region, residues 132-141, binds to the SH3 domain of the Lck protein. We show here that the other Lck-binding domain, residues 104-113, binds to the carboxyl-terminal half of Lck and that this binding does not require the Lck SH3 domain. Mutated Tip containing only one functional Lck-binding domain can bind stably to Lck, although not as strongly as wild-type Tip. Interaction of Tip with Lck through either Lck-binding domain increases the activity of Lck in vivo. Simultaneous binding of both domains is required for maximal activation of Lck. The transient expression of Tip in T cells was found to stimulate both Stat3-dependent and NF-AT-dependent transcription. Mutant forms of Tip lacking one or the other of the two Lck-binding domains retained the ability to stimulate Stat3-dependent transcription. Tip lacking the proline-rich Lck-binding domain exhibited almost wild-type activity in this assay. In contrast, ablation of either Lck-binding domain abolished the ability of Tip to stimulate NF-AT-dependent transcription. Full biological activity of Tip, therefore, appears to require both Lck-binding domains.
Subject(s)
Herpesvirus 2, Saimiriine/physiology , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Phosphoproteins/metabolism , Viral Proteins/metabolism , Binding Sites , Cell Line , DNA-Binding Proteins/metabolism , Enzyme Activation , Humans , Jurkat Cells , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/chemistry , Models, Molecular , Mutation , Phosphoproteins/chemistry , Phosphoproteins/genetics , Protein Binding , Protein Structure, Tertiary , STAT3 Transcription Factor , T-Lymphocytes/metabolism , T-Lymphocytes/virology , Trans-Activators/metabolism , Viral Proteins/chemistry , Viral Proteins/genetics , src Homology DomainsABSTRACT
Signal transducers and activators of transcription (STATs) are latent cytoplasmic transcription factors that transduce signals from the cell membrane to the nucleus upon activation by tyrosine phosphorylation. Several protein-tyrosine kinases can induce phosphorylation of STATs in cells, including Janus kinase (JAK) and Src family kinases. One STAT family member, Stat3, is constitutively activated in Src-transformed NIH3T3 cells and is required for cell transformation. However, it is not entirely clear whether Src kinase can phosphorylate Stat3 directly or through another pathway, such as JAK family kinases. To address this question, we investigated the phosphorylation of STATs in baculovirus-infected Sf-9 insect cells in the presence of Src. Our results show that Src can tyrosine-phosphorylate Stat1 and Stat3 but not Stat5 in this system. The phosphorylated Stat1 and Stat3 proteins are functionally activated, as measured by their abilities to specifically bind DNA oligonucleotide probes. In addition, the JAK family member Jak1 efficiently phosphorylates Stat1 but not Stat3 in Sf-9 cells. By contrast, we observe that AG490, a JAK family-selective inhibitor, and dominant negative Jak1 protein can significantly inhibit Stat3-induced DNA binding activity as well as Stat3-mediated gene activation in NIH3T3 cells. Furthermore, wild-type or kinase-inactive platelet-derived growth factor receptor enhances Stat3 activation by v-Src, consistent with the receptor serving a scaffolding function for recruitment and activation of Stat3. Our results demonstrate that Src kinase is capable of activating STATs in Sf-9 insect cells without expression of JAK family members; however, Jak1 and platelet-derived growth factor receptor are required for maximal Stat3 activation by Src kinase in mammalian cells. Based on these findings, we propose a model in which Jak1 serves to recruit Stat3 to a receptor complex with Src kinase, which in turn directly phosphorylates and activates Stat3 in Src-transformed fibroblasts.
Subject(s)
Cell Transformation, Neoplastic , DNA-Binding Proteins/metabolism , Genes, src , Oncogene Protein pp60(v-src)/metabolism , Protein-Tyrosine Kinases/metabolism , Signal Transduction/physiology , Trans-Activators/metabolism , 3T3 Cells , Animals , Cell Line, Transformed , DNA-Binding Proteins/genetics , Enzyme Activation , Fibrosarcoma , Gene Expression Regulation , Humans , Janus Kinase 1 , Mice , Phosphorylation , Protein-Tyrosine Kinases/genetics , Recombinant Proteins/metabolism , STAT1 Transcription Factor , STAT3 Transcription Factor , Spodoptera , Trans-Activators/genetics , Transcriptional Activation , Transfection , Tumor Cells, CulturedABSTRACT
The Tip protein of herpesvirus saimiri 484 binds to the Lck tyrosine-protein kinase at two sites and activates it dramatically. Lck has been shown previously to be activated by either phosphorylation of Tyr394 or dephosphorylation of Tyr505. We examined here whether a change in the phosphorylation of either site was required for the activation of Lck by Tip. Remarkably, mutation of both regulatory sites of tyrosine phosphorylation did not prevent activation of Lck by Tip either in vivo or in a cell free in vitro system. Tip therefore appears to be able to activate Lck through an induced conformational change that does not necessarily involve altered phosphorylation of the kinase. Tip may represent the prototype of a novel type of regulator of tyrosine-protein kinases.
Subject(s)
Herpesvirus 2, Saimiriine/metabolism , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Phosphoproteins/metabolism , Viral Proteins/metabolism , Cell Line , Enzyme Activation , Humans , Mutagenesis , Phosphorylation , Protein BindingABSTRACT
Type I interferons (IFNs) are a family of cytokines that have antiviral and antiproliferative effects. Data regarding the processes by which these cytokines transduce signals from the cell membrane to the nucleus are becoming increasingly complex. The most characterized pathway is via JAK-STAT signaling. Previous studies established a potential role for the Src-family kinase Lck in JAK-STAT signaling. Therefore, this study was designed to analyze the role of Lck in IFN-alpha signaling by using the Jurkat, JCam (an Lck-defective cell line derived from Jurkat), and JCam/Lck (JCam cells with Lck restored). The results show that IFN-alpha can induce MAPK activity, but only in cells containing Lck. Furthermore, STATs1 and -3 are effectively phosphorylated and activated to bind DNA in the absence of Lck expression in IFN-alpha-treated cells. Finally, the results demonstrate that IFN-alpha exerts an antiproliferative effect in all three cell lines. These data indicate that Lck and active MAPK do not affect IFN-alpha-induced growth arrest or induction of STAT1s1 and -3 DNA binding ability.
Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/physiology , DNA-Binding Proteins/metabolism , DNA/metabolism , Interferon-alpha/pharmacology , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/physiology , T-Lymphocytes/drug effects , Trans-Activators/metabolism , Cell Division/drug effects , Cell Line , Humans , Phosphorylation , STAT1 Transcription Factor , STAT3 Transcription Factor , T-Lymphocytes/physiologyABSTRACT
Constitutive activation of signal transducers and activators of transcription (STATs) has been associated with oncogenesis. Previously, a protein required for T-cell transformation by the DNA tumor virus herpesvirus saimiri (HVS) strain 484, designated tyrosine kinase-interacting protein (Tip-484), was shown to interact with and dramatically upregulate the activity of the STATs in an Lck-dependent manner. The minimal region of Tip-484 responsible for binding Lck was defined as a 10-residue C-terminal Src-related kinase homology domain, an 18-amino-acid spacer, and a 10-residue potential SH3 binding domain. This region is termed the LBD (for Lck binding domain). The present data show that only the LBD of Tip-484 is needed to activate Lck in vitro and in vivo. Finally, the LBD was shown to form a complex with STAT3 in vitro, and expression of the LBD in T cells led to STAT3 activation equal to that of full-length Tip-484. These studies demonstrate that the 48-amino-acid LBD of Tip-484 can perform as effectively as the full-length protein in vitro and in vivo.
Subject(s)
DNA-Binding Proteins/metabolism , Herpesvirus 2, Saimiriine/metabolism , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Phosphoproteins/metabolism , Trans-Activators/metabolism , Viral Proteins/metabolism , Binding Sites , Enzyme Activation , Humans , Jurkat Cells , Phosphoproteins/genetics , Recombinant Fusion Proteins/metabolism , STAT3 Transcription Factor , T-Lymphocytes , Viral Proteins/geneticsABSTRACT
Constitutive activation of the Src-family kinase Lck has been shown to lead to transformation. Constitutive activation of the STAT pathway of transcription factors has also been shown to be involved in transformation. An oncogenic form of the prototypical member of the Src-family, v-Src, has been shown to activate STAT3, and this activation is required for v-Src's transforming ability. To investigate whether Lck could directly activate STAT3, a baculovirus expression system was utilised. When Lck and STAT3 were coexpressed, STAT3 was found to have enhanced tyrosine phosphorylation and DNA binding activity. This finding was confirmed with experiments where exogenous Lck was added to baculovirus produced STAT3. Moreover, the activation of STAT3 by exogenous Lck could be attenuated by the Lck-specific inhibitor PP1. In addition, mammalian cells stably expressing a constitutively activated form of Lck were shown to have activated STAT3. These data provide strong evidence that, like v-Src, Lck can also directly activate STAT3, which contributes to the transformation process.
Subject(s)
DNA-Binding Proteins/metabolism , DNA/metabolism , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Trans-Activators/metabolism , Animals , Baculoviridae , Cell Line , DNA-Binding Proteins/genetics , Enzyme Activation , Enzyme Inhibitors/pharmacology , Gene Expression , Glutathione Transferase/genetics , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/genetics , Mice , Phosphorylation , Protein Binding , Proteins/pharmacology , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , STAT3 Transcription Factor , Spodoptera/cytology , T-Lymphocytes/metabolism , Trans-Activators/genetics , Tyrosine/metabolismABSTRACT
The recently identified human herpesvirus 8 (HHV-8, or Kaposi's sarcoma-associated herpesvirus) has been implicated in the etiology of both Kaposi's sarcoma (KS) and primary effusion (body cavity-based) lymphoma (PEL) (Y. Chang et al., Science 266:1865-1869, 1994; P. S. Moore et al., J. Virol. 70:549-558, 1996). An important feature of the association of HHV-8 with these malignancies is the expression of an abundant, latency-associated 0.7-kb transcript, T0. 7 (W. Zhong et al., Proc. Natl. Acad. Sci. USA 93:6641-6646, 1996). T0.7 is found in all stages in nearly all KS tumors of different epidemiologic origin, including AIDS-associated, African endemic, and classical KS (K. A. Staskus et al., J. Virol. 71:715-719, 1997), as well as in a body cavity-based lymphoma-derived cell line, BCBL-1, that is latently infected with HHV-8 (R. Renne et al., Nat. Med. 2:342-346, 1996). T0.7 encodes a unique HHV-8 open reading frame, K12, also known as kaposin. In this study, we report that the kaposin gene induced tumorigenic transformation. Constructs with kaposin expressed either from its endogenous promoter or from a heterologous promoter induced focal transformation upon transfection into Rat-3 cells. All transformed Rat-3 cell lines containing kaposin sequences produced high-grade, highly vascular, undifferentiated sarcomas upon subcutaneous injection of athymic nu/nu mice. Tumor-derived cell lines expressed kaposin mRNA, suggesting a role in the maintenance of the transformed phenotype. Furthermore, kaposin protein was detected in transformed and tumor-derived cells by immunofluorescence and localized to the cytoplasm. More importantly, expression of kaposin protein was also detected in the PEL cell lines BCBL-1 and KS-1. These findings demonstrate the oncogenic potential of kaposin and suggest its possible role in the development of KS and other HHV-8-associated malignancies.
Subject(s)
Genes, Viral , Herpesvirus 8, Human/genetics , Oncogenes , Amino Acid Sequence , Animals , Chromosome Mapping , Humans , Mice , Molecular Sequence Data , Open Reading Frames/genetics , Viral Proteins/geneticsABSTRACT
OBJECTIVE: Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, has been implicated as the causative agent of Kaposi's sarcoma. Retrospective studies show that the risk of development of Kaposi's sarcoma is significantly lower in AIDS patients who received ganciclovir or phosphonoformic acid (PFA) therapy. Therefore, in vitro antiviral drug sensitivity of KSHV was studied. METHODS: The KSHV genome is a latent episome in lymphoma cells such as the BCBL-1 cell line. Lytic KSHV DNA synthesis is induced by the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate in BCBL-1 cells; this system was used to evaluate the effects of antiviral drugs on KSHV DNA synthesis. RESULTS: Linear (lytic) KSHV DNA synthesis and virus secretion was inhibited in BCBL-1 cell cultures by cidofovir (median inhibitory concentration, 0.05 microM), ganciclovir (5.1 microM) and PFA (97 microM), and by aciclovir (75 microM). Prolonged incubation of BCBL-1 cells with antiviral drugs had no effect on episomal KSHV DNA synthesis. CONCLUSIONS: The antiviral drug assay developed shows that KSHV is very sensitive to cidofovir, moderately sensitive to ganciclovir and PFA, and weakly sensitive to aciclovir. Therefore, low doses of cidofovir, or high doses of PFA or ganciclovir could suppress clinical reactivation of KSHV. Antiviral drugs did not inhibit episomal virus DNA synthesis, suggesting that the latent form of viral DNA is replicated by host DNA polymerases. Consequently, no benefit can be expected from antiviral drugs in KSHV-positive B-cell lymphomas or during latency.
Subject(s)
Antiviral Agents/pharmacology , Herpesvirus 8, Human/drug effects , Organophosphonates , Sarcoma, Kaposi/drug therapy , Acyclovir/pharmacology , Carcinogens/pharmacology , Cidofovir , Cytosine/analogs & derivatives , Cytosine/pharmacology , DNA, Viral/drug effects , DNA, Viral/metabolism , DNA-Directed DNA Polymerase/metabolism , Foscarnet/pharmacology , Ganciclovir/pharmacology , Herpesvirus 8, Human/growth & development , Humans , Microbial Sensitivity Tests , Organophosphorus Compounds/pharmacology , Phorbol 12,13-Dibutyrate/pharmacology , Thymidine/metabolism , Tumor Cells, Cultured , Virus Latency/drug effectsABSTRACT
Signal transducers and activators of transcription (STATs) relay signals from activated cell surface receptors directly to the nucleus. Previously, a protein required for T-cell transformation by the DNA tumor virus herpesvirus saimiri (HVS) and designated tyrosine kinase interacting protein (Tip-484) was shown to interact with and dramatically upregulate the activity of p56lck. p56lck is a nonreceptor tyrosine kinase that is essential for signaling by the T-cell receptor and also interacts with the CD4, CD8, and interleukin-2 receptors. The present data show activation of STAT1 and -3 by Tip-484. STAT1 and -3 were also found to complex with glutathione S-transferase-Tip-484 only in the presence of p56lck, and STAT3 was shown to be phosphorylated by the Tip-484-p56lck multiprotein complex in vitro. Infection of T cells with HVS or expression of recombinant Tip-484 significantly increased the DNA-binding activity of the STAT1 and STAT3 transcription factors in nuclear extracts and also increased the phosphorylation of STAT3 in vivo. This is the first report of STAT activation by a DNA tumor virus protein. Moreover, these studies demonstrate that p56lck is required for STAT activation by Tip-484.
Subject(s)
DNA-Binding Proteins/metabolism , Herpesvirus 2, Saimiriine/metabolism , Phosphoproteins/metabolism , Trans-Activators/metabolism , Transcriptional Activation , Viral Proteins/metabolism , src-Family Kinases/metabolism , Animals , DNA/metabolism , Humans , Jurkat Cells , Lymphocyte Specific Protein Tyrosine Kinase p56(lck) , Phosphoproteins/genetics , Phosphorylation , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , STAT1 Transcription Factor , STAT3 Transcription Factor , Substrate Specificity , Up-Regulation , Viral Proteins/genetics , src-Family Kinases/geneticsABSTRACT
Herpesvirus saimiri (HVS) is a T-cell-specific transforming and oncogenic virus. A protein encoded by HVS known as Tip-484 (for tyrosine kinase interacting protein from HVS strain 484) is required for this transformation. Tip-484 binds specifically to the nonreceptor protein tyrosine kinase p56lck. By transfecting Tip-484 into T cells, we now show that this interaction leads to a several hundred-fold increase in the kinase activity of p56lck. Tip-484 is part of a protein complex which is dependent on the presence of p56lck and is phosphorylated. We also show that two of the complexed proteins represent two phosphorylated forms of Tip-484. Furthermore, the p56lck kinase activity in HVS-infected human peripheral blood T lymphocytes was at least ninefold higher than that in noninfected control cells and significantly decreased in cells infected with a Tip-484 deletion mutant virus. Finally, we report that Tip-484 is required for oncogenesis in rabbits by the survival of rabbits inoculated with Tip-484 deletion mutant HVS. The data demonstrate dramatic stimulation of the signaling pathway of p56lck. This effect can contribute to the molecular mechanisms that lead to sustained autocrine secretion of growth factors, permanent T-cell growth, and ultimately lymphocytic tumor formation.
Subject(s)
Herpesvirus 2, Saimiriine/metabolism , Phosphoproteins/metabolism , T-Lymphocytes/metabolism , Viral Envelope Proteins/metabolism , Viral Proteins/metabolism , src-Family Kinases/metabolism , Animals , Humans , Jurkat Cells , Lymphocyte Specific Protein Tyrosine Kinase p56(lck) , Oncogenes , Phosphoproteins/genetics , Phosphorylation , Rabbits , T-Lymphocytes/cytology , Transformation, Genetic , Viral Envelope Proteins/genetics , Viral Proteins/geneticsABSTRACT
Herpesvirus saimiri is a lymphotropic herpesvirus capable of immortalizing and transforming T cells both in vitro and in vivo. Immortalized and transformed T cells harbor several copies of the viral genome as a persisting genome. The mapping of the cis-acting genetic cis-acting segment (oriP) required for viral episomal maintenance is reported here. Viral DNA fragments that potentially contain oriP were cloned into a plasmid that contains the hygromycin resistance gene. After several round of subcloning followed by transfection, oriP was mapped to a 1.955-kb viral segment. This viral fragment permits stable plasmid replication without deletion or rearrangement as well as episomal maintenance without integration or recombination. The function of oriP depends on a trans-acting factor(s) encoded by the viral genome. The 1.955-kb viral segment includes a dyad symmetry region located between two small nuclear RNA genes and is located upstream of the dihydrofolate reductase gene homolog. Therefore, this oriP contains novel elements distinct from those of other DNA viruses.
Subject(s)
Cinnamates , DNA, Viral/physiology , Herpesvirus 2, Saimiriine/genetics , T-Lymphocytes/virology , Virus Replication , Animals , Base Sequence , Cell Line , Cell Transformation, Viral , Cloning, Molecular , DNA Replication , DNA, Viral/genetics , Drug Resistance , Herpesvirus 2, Saimiriine/physiology , Humans , Hygromycin B/analogs & derivatives , Hygromycin B/pharmacology , Molecular Sequence Data , Plasmids/genetics , Rabbits , Replication Origin , T-Lymphocytes/cytology , Trans-Activators/genetics , Trans-Activators/physiology , TransfectionABSTRACT
ORF-2, a 32-kDa viral protein expressed by herpesvirus saimiri-transformed lymphocytes, is essential for transformation and is expressed on the plasma membrane of transformed cells. The current work now shows that most (approximately 80%) of ORF-2 resides in the cytoplasm, while only a small portion protrudes from the cell surface. Expressed as a glutathione S-transferase fusion protein, ORF-2 was found to interact with a 56-kDa cellular protein in untransformed, herpesvirus saimiri-transformed, and Jurkat lymphocytes. Microsequencing proved that this protein is the lymphocyte-specific tyrosine protein kinase p56lck. Two regions of ORF-2 were found to be required for p56lck interaction. Current evidence suggests that the interaction of ORF-2 with p56lck plays a key role in the specific transformation of T lymphocytes to an interleukin-2-independent phenotype.
Subject(s)
Herpesvirus 2, Saimiriine/metabolism , Interleukin-2/metabolism , Viral Envelope Proteins/metabolism , src-Family Kinases/metabolism , Amino Acid Sequence , Animals , Binding Sites , Cells, Cultured , Herpesvirus 2, Saimiriine/genetics , Humans , Lymphocyte Specific Protein Tyrosine Kinase p56(lck) , Molecular Sequence Data , Open Reading Frames , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Serine Endopeptidases/metabolism , T-Lymphocytes/cytology , Viral Envelope Proteins/chemistryABSTRACT
Germline transcription of the immunoglobulin (Ig) locus is felt to play an important role in B cell differentiation. Similar transcripts are also found in neoplastic myeloid cells, but are of unknown significance. We have mapped these RNAs using reverse transcriptase polymerase chain reaction amplification. Unlike B cell transcripts, the majority of myeloid mu transcripts do not contain amplifiable enhancer sequence or complete 5' sequence. The extent of this deletion is related to the degree of myeloid maturation, with transcripts in the most primitive myeloid cells more closely resembling those in B cells. Variable 3'-splicing patterns are also observed in myeloid cells, unlike the single pattern identified in early B cells. Using primers which span the region from the 3' end of C mu 4 to the 5' end of the second membrane exon (M2), the splice sites between C mu 4 and M1, and between M1 and M2 have been analyzed. Our data suggest that factors important in initiation of germline mu transcription are present in both B lymphoid and myeloid cells, but that lineage-specific modifying factors alter this expression during myeloid maturation. Thus, the finding of Ig transcripts and other evidence of B lymphoid differentiation in acute myelogenous leukemia most likely reflects a retained common hematopoietic gene program.
Subject(s)
B-Lymphocytes/immunology , Immunoglobulin mu-Chains/genetics , Leukemia, Myeloid/immunology , RNA/genetics , B-Lymphocytes/pathology , Gene Expression Regulation, Neoplastic , Humans , Leukemia, Myeloid/genetics , RNA Splicing , Transcription, Genetic , Tumor Cells, CulturedABSTRACT
A region of the herpesvirus saimiri genome encoding an mRNA with two open reading frames (ORFs) has been identified to be essential for transformation of T cells. Deletion of either ORF resulted in the loss of transforming ability. ORF-1 has been shown to code for a collagen-like oncoprotein. This study shows for the first time that the bicistronic mRNA can translate a 32-kDa protein from ORF-2. Polyclonal serum to ORF-2 was generated by using a glutathione fusion protein. Using this antiserum, ORF-2 was localized in cell membranes and is expressed on the outer cell membrane. The half-life of this membrane protein was found to be about 5.5 h. Limited sequence similarity was found between ORF-2 and interleukin-11; however, no secretion of ORF-2 protein was detected in supernatants from transformed cells. Further studies are required to investigate the potential interaction with the interleukin-11 receptor.
Subject(s)
Cell Transformation, Viral , Herpesvirus 2, Saimiriine/genetics , Interleukin-2/physiology , Lymphocyte Activation , Membrane Proteins/physiology , T-Lymphocytes/virology , Viral Proteins/physiology , Animals , Interleukin-11/physiology , Open Reading Frames , RabbitsABSTRACT
2-Anilinopurines and 6-anilinopyrimidines bearing 3,4- or 3,5-dichloro substituents in the anilino ring inhibited virus-specific DNA synthesis by human cytomegalovirus (HCMV)-infected human embryonic lung (HEL) cells in culture. In general, active compounds had moderate to low selectivity for viral vs host cell DNA synthesis. Nucleoside and acyclonucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited both HCMV and cellular DNA synthesis at similar concentrations. 2-Amino-4-chloro-6-(3,5-dichloroanilino)pyrimidine and several related compounds inhibited HCMV growth in yield reduction assays at concentrations that were nontoxic to HEL cells.
Subject(s)
Antiviral Agents/pharmacology , Cytomegalovirus/drug effects , Purine Nucleosides/pharmacology , Purines/pharmacology , Pyrimidines/pharmacology , Aniline Compounds/chemistry , Antiviral Agents/chemistry , Cell Division/drug effects , Cell Line , Cytomegalovirus/enzymology , Cytomegalovirus/physiology , DNA-Directed DNA Polymerase/metabolism , Halogens/chemistry , Humans , Purine Nucleosides/chemistry , Purines/chemistry , Pyrimidines/chemistry , Virus Replication/drug effectsABSTRACT
Herpes simplex virus type 1 (HSV1) encodes a heterotrimeric helicase-primase comprised of the products of three of the seven DNA replication-specific genes. Several dihalo-substituted derivatives of N2-phenylguanines and 2-anilinoadenines weakly inhibited the intrinsic DNA-dependent NTPase activity of the HSV1 helicase-primase, and these compounds inhibited the DNA-unwinding activity of the enzyme. The primase activity of the enzyme was strongly inhibited by 3,4- and 3,5-dichloroanilino derivatives of adenine and 2-aminopyrimidines. These compounds and nucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited viral DNA synthesis in HSV1-infected HeLa cells in culture but also inhibited cellular DNA synthesis, likely as a result of inhibition of cellular primase and/or DNA polymerases.
Subject(s)
DNA Helicases/antagonists & inhibitors , Herpesvirus 1, Human/enzymology , Purines/pharmacology , Pyrimidines/pharmacology , RNA Nucleotidyltransferases/antagonists & inhibitors , Aniline Compounds , Antiviral Agents/pharmacology , Cell Division/drug effects , DNA Primase , DNA, Viral/biosynthesis , DNA, Viral/drug effects , HeLa Cells , Herpesvirus 1, Human/genetics , HumansABSTRACT
Herpesvirus saimiri (H. saimiri) is a highly oncogenic lymphotropic herpesvirus which can immortalize T lymphocytes and cause tumors in rabbits and New World monkeys. T cells infected with strain 484-77 of group C express four viral U-like small RNAs (HSUR1-4) and a 1.2-kb mRNA which encodes open reading frames ORF-1 and ORF-2. ORF-1 encodes a collagen-like oncoprotein. Deletion mutation analysis showed that ORF-1 and ORF-2 are essential for IL-2 independent growth of human T cells infected with H. saimiri. An earlier study also demonstrated that H. saimiri-immortalized cells carry functional IL-2 receptors. The work presented in this report investigated whether IL-2 and IL-4 is produced by H. saimiri-immortalized T lymphocytes. Both IL-2 mRNA and IL-4 mRNA were detected in various monkey T cells as well as human peripheral blood lymphocytes infected with wild-type H. saimiri. Secretion of IL-2 was suggested by cyclosporin A inhibition. IL-4 secretion by monkey T cell cultures was demonstrated by a bioassay and inhibition of bioactivity by an antibody to IL-4. The data also show that recombinant IL-4 stimulate H. saimiri-immortalized T cells; thus, IL-4 receptors are expressed. However, antibodies to human IL-4, IL-4 receptor, or soluble IL-4 receptor did not curtail growth of transformed cells. T cells infected with ORF-1 and ORF-2 deletion mutants expressed no detectable IL-2 mRNA. ORF-1, ORF-2, HSUR1, and HSUR2, were all essential for expression of IL-4 mRNA. These data are consistent with the hypothesis that H. saimiri-immortalized monkey and human T lymphocytes proliferate through autocrine secretion of IL-2 and that ORF-1, ORF-2, and HSUR sequences of the virus are involved in expression of lymphokines.
Subject(s)
Cell Transformation, Viral , Herpesvirus 2, Saimiriine/metabolism , Interleukin-2/biosynthesis , Interleukin-4/biosynthesis , T-Lymphocytes/virology , Animals , Base Sequence , Cell Count , Cell Division/drug effects , Cell Line, Transformed , Cyclosporine , Gene Expression Regulation, Viral , Haplorhini , Herpesvirus 2, Saimiriine/genetics , Humans , Interleukin-2/pharmacology , Interleukin-4/pharmacology , Lymphocyte Activation , Molecular Sequence Data , Open Reading Frames/genetics , RNA, Messenger/biosynthesis , RNA, Small Nuclear/genetics , Sequence Deletion/physiology , T-Lymphocytes/cytology , T-Lymphocytes/metabolismABSTRACT
Herpesvirus saimiri (H. saimiri) can transform T lymphocytes and cause lymphoid tumors in rabbits and New World monkeys. H. saimiri-immortalized T cells express IL-2 and IL-4. The putative oncogenes of a group C strain of H. saimiri have been mapped to a region of the unique L-DNA which includes genes encoding four U-like small nuclear RNAs (HSUR1-HSUR4). Jurkat T cells express a 70 kD RNA binding factor (AUBF70) which binds HSUR2. Here we examined AUBF70 expression in resting and mitogen-stimulated human peripheral blood T cells and its sequence specificity and subcellular distribution. Band-shift assays demonstrated that resting human T cells express low amounts of AUBF70 which is induced by mitogen treatment. IL-2 and IL-4 mRNAs were co-induced with AUBF70 suggesting that AUBF70 is a positive regulator of lymphokine gene expression. Normal resting, mitogen-stimulated, and leukemic Jurkat T cells all express AUBF70 with virtually identical V8 proteolytic enzyme digestion patterns. Northern blots demonstrated that HSUR1 and HSUR2 are localized both in the nucleus and cytoplasm. HSUR2 accumulate in the cytoplasm in the presence of actinomycin D, which is consistent with re-transport of HSURs to the nucleus by (an) unstable factor(s). We hypothesize that HSUR1 and 2 transport AUBF70 from the cytoplasm to the nucleus; in the nucleus, AUBF70 binds and stabilizes lymphokine transcripts. Increased stability of lymphokine mRNAs could contribute to oncogenic transformation induced by H. saimiri.
Subject(s)
Herpesvirus 2, Saimiriine/genetics , Interleukin-2/genetics , Interleukin-4/genetics , Mitogens/pharmacology , RNA, Messenger/analysis , RNA, Small Nuclear/metabolism , RNA-Binding Proteins/biosynthesis , T-Lymphocytes/metabolism , Base Sequence , Cell Line, Transformed , Dactinomycin/pharmacology , Humans , Lymphocyte Activation , Molecular Sequence DataABSTRACT
Herpesvirus saimiri, an oncogenic gamma herpesvirus of primates, is the only eukaryotic virus that carries the entire metabolic gene set for a complex biochemical synthesis. Every element of the thymidine synthesis gene cascade is present in the virus, and their function is probably related to the uniquely high A + T content of the genome. Although one member of the gene set, dihydrofolate reductase (DHFR), is mapped in a region required for oncogenesis, very little is known of the expression and function of this gene in transformed cells. We report the expression of the DHFR sequence on a novel, unique tricistronic transcript in virally transformed tumor cells. The DHFR sequence is the first open reading frame on a 5.3 kb minor transcript. Alpha-amanitine sensitivity indicates that it is an RNA polymerase II transcript, and since it is also polyadenylated it appears to be a functional, relatively unstable (half-life 3 hr) mRNA. Initiation of transcription uniquely overlaps with the HSUR3 small RNA gene. Expression of the small transcript appears to be alpha-amanitine resistant, implicating polymerase III transcription. Together with the remarkably low-level expression of HSUR3 in tumor cells, the data may indicate transcription interference between two different RNA polymerases, with unusual overlapping regulation and initiation.